Current studies have shown higher levels of MMP-2 and MMP-9 in patients with obesity, metabolic syndrome, and T2DM compared to control groups [5,14,20,22]. The gene discussed is MMP9; the disease is obesity due to melanocortin 4 receptor deficiency.